Table 4.
Univariate and Multivariable Analysis for Biochemical Predictors of PSD in Patients With ACI
| Univariate | Multivariate | |||
|---|---|---|---|---|
| OR (95% CI) | P value | OR (95% CI) | P value | |
| TT3, μg/L | 0.00(0.000,0.04) | < 0.001# | ||
| TT4, μg/L | 0.99(0.95,1.03) | 0.582 | ||
| TSH, uIU/mL | 1.15(0.66,2.03) | 0.625 | ||
| LDL, mmol/L | 0.89(0.56,1.41) | 0.618 | ||
| HDL, mmol/L | 0.66(0.17,2.56) | 0.438 | ||
| FBG, mmol/L | 1.11(0.90,1.36) | 0.337 | ||
| 2hPBG, mmol/L | 1.03(0.94,1.13) | 0.543 | ||
| HbA1c, % | 0.97(0.74,1.26) | 0.790 | ||
| NE, ng/L | 0.99(0.99,0.99) | < 0.001# | ||
| DA, ng/L | 0.85(0.79,0.90) | < 0.001# | 0.64(0.45,0.91) | 0.014* |
| 5-HT, ng/L | 0.99(0.99,1.00) | < 0.001# | 0.99(0.98,1.00) | 0.046* |
| IL-6, ng/L | 3.23(1.90,5.48) | < 0.001# | ||
| TNF-α, ng/L | 1.03(1.02,1.04) | < 0.001# | 1.05(1.00,1.09) | 0.044* |
| NGF, ng/L | 0.55(0.41,0.76) | < 0.000# | 0.06(0.01,0.67) | 0.022* |
| CGRP, pg/ml | 1.03(0.99,1.07) | 0.146 | ||
CI confidence interval, CGRP calcitonin gene-related peptide, DA dopamine, FBG fasting blood glucose, 5-HT 5-hydroxytryptamine, HbA1c glycosylated hemoglobin, type A1c, HDL high-density lipoprotein, IL-6 interleukin 6, LDL low-density lipoprotein, NE norepinephrine, NGF nerve growth factor, OR odds ratio, 2hPBG 2-h postprandial blood glucose, PSD post-stroke depression, SD standard deviation, TNF-α tumor necrosis factor-α, TSH thyroid-stimulating hormone, TT3 total triiodothyronine, TT4 total thyroxine
* P < 0.05; # P < 0.001